基本信息
出版地:ENGLAND
期刊简称:DRUG DES DEV THER
通讯地址:PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752
创刊年份:2007
发行周期:1 issue/year
涉及方向:CHEMISTRY, MEDICINAL - PHARMACOLOGY & PHARMACY
ESSN:
英文期刊简介
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.
The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.
Specific topics covered by the journal include:
Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.
中文期刊简介
《Drug Design Development And Therapy》是一本由DOVE MEDICAL PRESS LTD出版商出版的专业医学期刊，该刊创刊于2007年，刊期1 issue/year，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学 3区，小类学科：药物化学 3区；药学 3区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖药物化学等领域，旨在及时、准确、全面地报道国内外药物化学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2021年影响因子为4.319，平均审稿速度>12周，或约稿。
